UNSPSC 51282941: Prulifloxacin

This classification denotes a quinolone antibiotic with the molecular formula C21H20FN3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J42298IESW, chemically known as 1h,4h-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1-piperazinyl)-4-oxo- but generally known as prulifloxacin, which bears US NIH Compound Identifier 65947. European Medicines Agency schedules Prulifloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10156MIG.

UNSPSC 51282941 Prulifloxacin is a Commodity code for a specific fluoroquinolone antibiotic, but recent state and local procurement activity under this code shows minimal direct solicitation for the drug itself. The opportunities tagged to this code instead reflect broader pharmaceutical procurement across multiple categories — naloxone and drug deactivation systems, generic multi-source pharmaceuticals through cooperative purchasing, and medical and first aid supplies for emergency response. State and local governments do purchase pharmaceutical products including antibiotics and prescription medications through health departments, emergency management agencies, and fire departments, typically via competitive bidding (IFB), requests for proposal (RFP), or cooperative purchasing alliances. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The code does not show issuing bodies soliciting prulifloxacin by name or in isolated lots; instead, procurement activity clusters around bundled pharmaceutical sourcing, emergency medical supplies, and direct-to-manufacturer prescription programs.

Geographic activity centers on Florida (Seminole County naloxone procurement, City of Tampa fire rescue medical supplies), Texas (HHS Commission direct-to-manufacturer prescription initiative), and the upper Midwest through MMCAP, which serves Minnesota, Oregon, and participating state and local members. Recent representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 drug deactivation systems annually; the City of Tampa's ITB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies to the Fire Department Rescue Division, estimated at $700,000 and sheltered for certified Small Local Business Enterprises with a 5% bid discount; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers effective July 1, 2026. The Texas HHS RFI (posted April 3, 2026) represents exploratory procurement for direct-to-manufacturer prescription programs but does not name specific drugs or values. Prulifloxacin as a named-drug procurement does not appear in recent state and local notices under this code.